SYNOPSIS A method employing six minutes of regional curarization with 0.5 mg D-tubocurarine and single fibre electromyographic measurements (SFEMG) was used in order to study the effect of an additional small dose of D-tubocurarine. The effect of the additional dose was most pronounced in terms of increased jitter, on motor end-plates with the initially highest jitter. The combination of regional curarization and SFEMG jitter recordings offers a sensitive technique for detecting mild effects of various drugs on neuromuscular transmission not detectable with decrement investigations.
Because of the normally high safety factor for neuromuscular transmission as shown in rats (Waser, 1960) , cats (Paton and Waud, 1967) , and in man, both in vitro (Elmqvist et al., 1964) and in vivo (St'alberg et al., 1975) , mild pharmacological and metabolic effects cannot be detected, so the safety factor for neuromuscular transmission needs to be reduced in order to reveal minor dysfunctions. Minimal further disturbances can then be detected in particular with single fibre electromyographic (SFEMG) jitter measurements (Ekstedt, 1964; Stalberg and Ekstedt, 1973) . The positive relationship between jitter and safety factor was demonstrated by (Stalberg et al. 1975) .
The aim of the present investigation was to study the effect of a small additional standard dose of D-tubocurarine on slightly curarized neuromuscular junctions employing a regional curare method (Torda and Klonymus, 1966; Foldes et al., 1968; Horowitz et al., 1975) in order to establish a sensitive method for determining the effects of pharmacological agents on the neuromuscular transmission.
METHODS
SINGLE FIBRE ELECTROMYOGRAPHY Single fibre (Accepted 15 April 1975.) 805 EMG recordings (SFEMG) were made with a sidehole SFEMG electrode with a recording surface of 25 ,um diameter. For detailed description of the method see Ekstedt (1964) and Stalberg (1966) .
Action potentials from two single muscle fibres belonging to the same motor unit are recorded as a potential pair. The neuromuscular jitter is due to a variability in the neuromuscular transmission time (Stalberg et al., 1971) and is expressed as mean value of the consecutive differences (MCD) of the intervals between the two components making up the potential pairs. The MCD was calculated off-line with a PDP 11-40 computer and with a time interval counter (Hewlett-Packard 5326B). The recordings were stored on analogue tape (AKAI X330). Also the mean value of the interval between the two components was calculated (MIPI= mean interpotential interval).
The jitter was studied after a preceding regional intravenous dose of D-tubocurarine, employing a method similar to that used in regional intravenous anaesthesia (Bier, 1908; Thorn-Alquist, 1966 ) and in regional curarization (Torda and Klonymus, 1966; Foldes et al., 1968; Horowitz et al., 1975) . A blood-pressure cuff around the right upper arm was insufflated to 200-250 mmHg and 0.5 mg D-tubocurarine in 20 ml NaCl was injected slowly into the dorsal vein of the right hand. The cuff was deflated after six minutes.
In the first three minutes after the cuff was released there were prominent impulse blockings and only after this time could potentials suitable for con-6Hans H. Schiller, Eric Stllberg, and Martin S. Schwartz (Ekstedt et al., 1974) were plotted relative to time. The change in jitter after the additional dose of D-tubocurarine was measured as the difference between the fitted maximal value one to four minutes after the injection and a value obtained by extrapolating the preinjection slope of the curve for this time (Fig. 1 ).
DECREMENT MEASUREMENTS Surface recordings were made from the right and left abductor digiti quinti muscle respectively at electrical supramaximal stimulation (Medelec NS6) of the ulnar nerve at the wrist at 2 Hz and pulse width 0.1 ms. The recordings were made during a period of 28 to 36 minutes. During the first six minutes the right arm was partially curarized with 0.5 mg D-tubocurarine regionally. In two subjects an additional 0.5 mg D-tubocurarine was given systemically three to five minutes after cuff release, two others received 30 Vg/kg, and two were not given the additional dose. The six minute period for the cuff was chosen as a significant decrement (more than 10%) and earliest signs of clinical weakness were found to begin after about four minutes. The decrement was measured as the percentage amplitude reduction of the negative peak between the first and the fourth response. In two additional experiments, the effects of six minutes ischaemia without drug were tested. SUBJECTS Investigations were made on 11 healthy subjects aged 25-45 years. Decrement measurements were carried out in five of them. Between two investigations on the same subject there was at least a 24 hour interval. The investigations were done in a warm room, the ambient temperature of which was maintained at 20-22°C.
RESULTS
SFEMG All action potential pairs recorded during the first minute after cuff release showed increased jitter (MCD > 50 ,ts) and most demonstrated partial neuromuscular blockings. After The dynamic changes in one trial after 0.5 mg D-tubocurarine injected intravenously into the left arm are seen in Fig. 1 included in Fig. 2 . A positive correlation between the initial jitter (20-75 ,us) and the maximal jitter (27-140 ,us), calculated as the mean of 500 discharges, is evident with a greater increase at higher initial jitter values. The correlation coefficient for the linear regression was 0.86 (Fig. 3) . In cases where the jitter exceeded about 80 ,us, occasional impulse blockings were observed. In a number of recordings repetitive discharges of the potential pairs were observed during the time period five to 10 minutes after cuff release.
The MIPI often showed pronounced changes with a maximal decrease or increase of 800 ,s.
In the experiment in which an additional 30 jig/kg D-tubocurarine was given, prominent impulse blockings were observed for over 10 minutes. A number of subjects had difficulty in maintaining a regular innervation rate, particularly after the additional dose. There was no significant change in the shape of the action potentials during the recordings. SURFACE RECORDINGS In two experiments with ischaemia alone there was no decrement one minute after cuff release. The decrements after ischaemia plus regional D-tubocurarine one minute after cuff release were 70, 60, 30, 27, 27, and 20% respectively. The decrements were halved after 10 minutes in the first three investigations. However, in the fourth, the decrement was normalized after three minutes. In the second and third trials an additional 0.5 mg was injected systemically after 10 minutes. The second dose did not change the progressive normalization of the curves. In the fifth and sixth experiments a systemic dose of 30 Vg/kg was given shortly after cuff release. In the partially curarized arm the slope of the decremental curve was flattened, corresponding to an additional 10%/ decrement from the expected values (Fig. 4) .
In the non-treated arm there were no effects on the decrement with the systemic injection of 0.5 mg or 30 ,ug/kg D-tubocurarine.
DISCUSSION
Regional injection of D-tubocurarine (Torda and Klonymus, 1966; Foldes et al., 1968; Horowitz et al., 1975) was used in the present study as the method for partial reduction of the neuromuscular safety factor. Substances injected into the forearm venous system after application of a cuff around the upper arm diffuse through the vascular bed as shown angiographically (Fleming et al., 1966) and with radio-labelled Transferrin . The relatively even distribution of the injected D-tubocurarine was indicated in the present investigation by widespread histamine response distal to the cuff and increased jitter values in all investigated sites. The increased jitter was due to D-tubocurarine and not to ischaemia, as the jitter normalized within one minute even after 45 minutes of ischaemia (Dahlbiick et al., 1970) .
The technique of regional curarization has been used for studying the effect of neuromuscular transmission with repetitive stimulation in normals and in patients with myasthenia gravis Horowitz et al., 1975) . In normal subjects 15 mg D-tubocurarine given systemically produces no decrement but 0.5 mg regional D-tubocurarine produces decremental response within five minutes , a feature which was also seen in the present investigation.
When regional partial curarization was employed, as low a dose as 30 jig/kg (2-3 mg) D-tubocurarine injected systemically affected the decrement in the pretreated arm. However, 0.5 mg D-tubocurarine used similarly did not affect the decrement. With SFEMG jitter measurements it is possible to detect minor neuromuscular disturbances even before impulse blockings occur (Ekstedt and Stalberg, 1969; Stalberg and Ekstedt, 1973 ) and weakness appears. As small a systemic dose of D-tubocurarine as 0.5 mg has a measurable effect on the jitter (Ekstedt and Stalberg, 1969; Stalberg et al., 1975) and this effect was greatly increased when the tested arm was pretreated with regional curarization. The increase of the jitter was greater for higher initial jitter values (Fig. 3) ; however, impulse blockings were rare. This small amount of blocking was not sufficient to produce (Naess, 1952; Waser, 1960; Thesleff and Quastel, 1965) . Any agent that produces further receptor blockade leads to increase in the jitter greater than that seen without previous partial curarization. Disturbances in impulse transmission are seen in a number of pathological conditions-for example, myasthenia gravis (Elmqvist et al., 1964) and reinnervation (Stalberg and Thiele, 1972) . Because of the reduced safety factor in these conditions, there may be more dysfunctions when these patients are given therapeutic doses of drugs that affect neuromuscular transmission such as neomycin (Elmqvist and Josefsson, 1962) , diphenylhydantoin (Norris et al., 1964) and others which would not affect normal subjects.
The described method for reduction of the safety factor by means of local partial curarization may be of importance for testing the effect on neuromuscular transmission of various agents. The combination of the method of regional curarization with SFEMG jitter measurements may allow the detection of minimal adverse effects on neuromuscular transmission of drugs at therapeutic levels.
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